Articles written by: Davis Scott

The Carlyle Group L.P. (TCGP)’s Financial Results Comparing With Principal Real Estate Income Fund (NYSE:PGZ)

Since The Carlyle Group L.P. (NASDAQ:TCGP) and Principal Real Estate Income Fund (NYSE:PGZ) are part of the Asset Management industry, they are influenced by compare. The influences particularly affect the analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership of both companies. Valuation and Earnings Gross Revenue Price/Sales Ratio […]

Comparing of Esperion Therapeutics Inc. (ESPR) and AzurRx BioPharma Inc. (NASDAQ:AZRX)

Esperion Therapeutics Inc. (NASDAQ:ESPR) and AzurRx BioPharma Inc. (NASDAQ:AZRX) are two firms in the Biotechnology that compete against each other. Below is a comparison of their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

ZIOPHARM Oncology Inc. (ZIOP)’s Financial Results Comparing With Sierra Oncology Inc. (NASDAQ:SRRA)

We will be comparing the differences between ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) and Sierra Oncology Inc. (NASDAQ:SRRA) as far as risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Westamerica Bancorporation (WABC) and SVB Financial Group (NASDAQ:SIVB) Contrasting side by side

This is therefore a contrasting of the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation in Westamerica Bancorporation (NASDAQ:WABC) and SVB Financial Group (NASDAQ:SIVB). The two are both Regional – Pacific Banks companies that compete with one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Acceleron Pharma Inc. (XLRN) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Comparison side by side

Both Acceleron Pharma Inc. (NASDAQ:XLRN) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) are each other’s competitor in the Biotechnology industry. Thus the contrast of their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acceleron Pharma Inc. […]

AVEO Pharmaceuticals Inc. (AVEO)’s Financial Results Comparing With Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

AVEO Pharmaceuticals Inc. (NASDAQ:AVEO) and Intra-Cellular Therapies Inc. (NASDAQ:ITCI), both competing one another are Biotechnology companies. We will compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AVEO Pharmaceuticals Inc. 1 25.40 N/A […]

Nuveen Ohio Quality Municipal Income Fund (NUO) and BlackRock Capital Investment Corporation (NASDAQ:BKCC) Comparing side by side

We are contrasting Nuveen Ohio Quality Municipal Income Fund (NYSE:NUO) and BlackRock Capital Investment Corporation (NASDAQ:BKCC) on their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. They both are Asset Management companies, competing one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Megalith Financial Acquisition Corp. (MFAC) and Evercore Inc. (NYSE:EVR) Contrasting side by side

Megalith Financial Acquisition Corp. (NYSE:MFAC) and Evercore Inc. (NYSE:EVR) are two firms in the Asset Management that compete against each other. Below is a comparison of their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]